Savara to present at the oppenheimer 33rd annual healthcare conference

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the oppenheimer 33rd annual healthcare conference on march 13, 2023 at 1:20pm et. a live webcast of the presentation will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.
SVRA Ratings Summary
SVRA Quant Ranking